Paul Fenn, MD
Foot and Ankle Surgery · Lafayette, LANPI 1720006687
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (39.0%), education and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Stryker at 34.6% of the total.
Across 31 payments — averaging $119.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1K
- ALON Medical Technology$1K
- Arthrex$439
- Next Science LLC$144
- Musculoskeletal Transplant Foundation Inc.$107
- Terumo BCT, Inc.$107
- plus $432 from 8 others
What the payments were for
- Travel & lodging$1,06529%
- Food & beverage$1,44939%
- Education$1,20032%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 15 | $1,285 |
| ALON Medical Technology | 1 | $1,200 |
| Arthrex | 1 | $439 |
| Next Science LLC | 2 | $144 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $107 |
| Terumo BCT, Inc. | 1 | $107 |
| In2bones USA, LLC | 1 | $106 |
| Zimmer Biomet | 1 | $71 |
| Pacira Therapeutics, Inc. | 3 | $53 |
| Dynasplint Systems Inc. | 1 | $50 |
| Carbofix Orthopedics Inc | 1 | $47 |
| Biom'up France SAS | 1 | $44 |
| Philips North America LLC | 1 | $39 |
| Spinal Simplicity, LLC | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$729
- Xperience$140
- BlastX$140
- AUGMENT$108
- PROPHECY$107
- Bone Marrow Aspirate Concentrate System$107
- Quantum Total Ankle$106
How this compares
$3,713 in reported general payments places this provider in the 60th percentile of 92 foot and ankle surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 70 | $961 |
| Tizanidine Hcl | 44 | $247 |
| Gabapentin | 18 | $143 |
| Methylprednisolone | 17 | $81 |
| Zolpidem Tartrate | 25 | $42 |
| Promethazine Hcl | 16 | $39 |
| Tramadol Hcl | 13 | $32 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Lafayette
- James NoriegaLafayette$11K
- Noah OliverLafayette$8K
- Christopher HebertLafayette$3K
- Jeffery GrizzaffiLafayette$2K
- Lauren GibsonLafayette$2K
- Brian BensonLeesville$278K
- Meredith WarnerBaton Rouge$232K
- Tyson GreenLake Charles$203K
- Bryon McKennaThibodaux$131K
- Mohamad IssaNew Orleans$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.